Support to clinical research by the management of experimental drugs in the various phases (supply chain, quality-quantity control, drug preparation, drug accountability). Activities in team with the principal investigator’s staff in management of the experimental protocols. Support and collaboration with Sponsors/CROs for the management of clinical trials.
1.20/28027 - Caccialanza R, Laviano A, Lobascio F, Montagna E, Bruno R, Ludovisi S, Corsico A. G, Di Sabatino A, Belliato M, Calvi M, Iacona I, Grugnetti G, Bonadeo E, Muzzi A, Cereda E.: Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol. Nutrition 2020 Jun;74:110835 Impact factor: 3.639
2.21/29864 - Savioli G, Ceresa IF, Giordano M, Ferrari I, Varesi A, Floris V, Esposito C, Croesi B, Ricevuti G, Calvi M, Bressan MA, Oddone E: The Reliability of Anamnestic Data in the Management of Clostridium Tetani Infection in Elderly. Front Med (Lausanne). 2021 Oct 28;8:684594 Impact factor: 5.093
3.22/30420 - Colaneri M, Di Benedetto A, Marvulli LN, Bocchio F, Cutti S, Marena C, Calvi M, Bruno R: Are people previously infected with SARS-CoV-2 likely to experience COVID-19 symptoms again after vaccination? Results from an Italian COVID-19 referral center. Human Vaccines Immunother. 2022 Dec 31;18(1):1920273. doi: 10.1080/21645515.2021.1920273. Epub 2021 Jun 11 Impact factor: 4.526
4.23/31569 - Vecchia M, Colaneri M, Sacchi P, Marvulli LN, Salvaderi A, Lanza J, Boschini S, Ragni F, Marone P, Cutti S, Muzzi A, Marena C, Calvi M, Scudeller L, Marone EM, Bruno R.: Implementation of an antimicrobial stewardship program in the Vascular Surgery ward of a university tertiary care hospital in Pavia, Northern Italy.
BMC Infect Dis. 2023 Mar 7;23(1):138. doi: 10.1186/s12879-023-08061-x. Impact factor: 3.7
5.23/31915 - Lasagna A, Mascaro F, Figini S, Basile S, Gambini G, Klersy C, Lenti MV, Di Sabatino A, Di Benedetto A, Calvi M, Bruno R, Sacchi P, Pedrazzoli P.: Impact of proton pump inhibitors on the onset of gastrointestinal immune-related adverse events during immunotherapy. Cancer Med. 2023 Oct;12(19):19530-19536. doi: 10.1002/cam4.6565. Epub 2023 Sep 22 Impact factor: 4
CNAO - Centro Nazionale di Adroterapia Oncologica (2023)
Fondazione Istituto Neurologico Casimiro Mondino (2023)
Dr. Federica Bocchio, Dr. Elena Brè, Dr. Barbara Croesi, Dr. Maria Cusato, Dr. A. Daneri, Dr. Alice Di Benedetto, Dr. Isabella Iacona, Dr. P. Legnazzi, Dr. Cristina Meazza, Dr. Giulia Rebagliati, Dr. Michela Tizzoni
Ultimo aggiornamento: 19/01/2026
